PMID: 8610157Apr 2, 1996Paper

Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein

Proceedings of the National Academy of Sciences of the United States of America
J B Davis, William E Van Nostrand

Abstract

Cerebrovascular amyloid beta-protein (Abeta) deposition is a pathological feature of several related disorders including Alzheimer disease and hereditary cerebral hemorrhage with amyloidosis Dutch-type (HCHWA-D). HCHWA-D is caused by a point mutation in the gene that encodes the Abeta precursor and results in a Glu --> Gln substitution at position 22 of Abeta. In comparison to Alzheimer disease, the cerebrovascular Abeta deposition in HCHWA-D is generally more severe, often resulting in intracerebral hemorrhage when patients reach 50 years of age. We recently reported that Abeta(1-42), but not the shorter Abeta(1-40) induces pathologic responses in cultured human leptomeningeal smooth muscle cells including cellular degeneration that is accompanied by a marked increase in the levels of cellular Abeta precursor and soluble Abeta peptide. In the present study, we show that the HCHWA-D mutation converts the normally nonpathologic Abeta(1-40) into a highly pathologic form of the peptide for cultured human leptomeningeal smooth muscle cells. These findings suggest that these altered functional properties of HCHWA-D mutated Abeta may contribute to the early and often severe cerebrovascular pathology that is the hallmark of this disor...Continue Reading

References

Jul 1, 1988·Journal of the Neurological Sciences·W LuyendijkB Frangione
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S G van DuinenB Frangione
Mar 1, 1987·Stroke; a Journal of Cerebral Circulation·H V Vinters
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Jun 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·A R WattendorffG T Bots
Sep 8, 1995·The Journal of Biological Chemistry·J Davis-Salinas, W E Van Nostrand
Jan 1, 1994·Acta Neuropathologica·H M Wisniewski, J Wegiel
Aug 29, 2012·Biochemical and Biophysical Research Communications·George G Glenner, Caine W Wong

❮ Previous
Next ❯

Citations

Jun 1, 1997·Annals of Neurology·S M Greenberg, B T Hyman
Nov 10, 2009·Cellular and Molecular Life Sciences : CMLS·A RostagnoJorge Ghiso
Feb 4, 2009·Cellular and Molecular Life Sciences : CMLS·R J S VianaC M P Rodrigues
Oct 24, 2003·Brain Research. Brain Research Reviews·Annemieke A M RensinkMarcel M Verbeek
Dec 18, 2003·Neurobiology of Disease·Marjolijn BornebroekChristine Van Broeckhoven
Nov 25, 1997·Brain Research. Brain Research Reviews·L C Walker
Jul 1, 1997·Brain Research. Molecular Brain Research·C CzechG Tremp
Dec 17, 2003·Neurobiology of Aging·Annemieke A M RensinkBerry Kremer
Oct 27, 2012·Accounts of Chemical Research·Jay T GoodwinDavid G Lynn
Apr 11, 2009·Biochemistry·Robert TyckoStephen C Meredith
Sep 24, 2009·Journal of the American Chemical Society·Richard S GlassTakuhei Yamamoto
Sep 23, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S FossatiA Rostagno
May 20, 2000·Annals of the New York Academy of Sciences·M M VerbeekR M De Waal
Apr 8, 2011·Science Translational Medicine·David M HoltzmanAlison M Goate
Apr 13, 2007·Neuro-degenerative Diseases·Verena H Finder, Rudi Glockshuber
Dec 10, 2008·Stroke; a Journal of Cerebral Circulation·Gregory J ZipfelJin-Moo Lee
Mar 4, 2014·PloS One·James L SearcyKaren Horsburgh
Jul 29, 2000·Biochemical and Biophysical Research Communications·D ParisM Mullan
Dec 11, 2013·Translational Stroke Research·Tanya L Cupino, Matthew K Zabel
Jan 1, 1997·Endothelium : Journal of Endothelial Cell Research·M HaseH Hayashi
Aug 25, 2009·Biochimica Et Biophysica Acta·Ming-Jen HsuChung Y Hsu
Aug 25, 2007·Pharmacology & Therapeutics·Mark A Findeis
Jun 17, 2004·Journal of Neurochemistry·Naoki YamamotoKatsuhiko Yanagisawa
Jun 4, 2004·Neuropathology and Applied Neurobiology·A A M RensinkM M Verbeek
Feb 26, 2009·Aging Cell·Julien BrubanFrédéric Mascarelli
Dec 22, 2005·The FEBS Journal·Kazufumi TakanoShigenori Kanaya
Apr 15, 2006·Brain Pathology·Martin C HerzigMathias Jucker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.